Şaban Keleşoğlu
Impact in
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
- Heart Rate Variability and Autonomic Control
Papers in
-
- Atrial Fibrillation Management and Outcomes 9
- Cardiovascular Disease and Adiposity 8
- Acute Myocardial Infarction Research 8
- Oncology 11
- Inflammatory Biomarkers in Disease Prognosis 11
- Co-authors
- Yücel Yılmaz (21 shared papers)Deniz Elçik (23 shared papers)Nihat Kalay (14 shared papers)Abdurrahman Oğuzhan (7 shared papers)Mehmet Güngör Kaya (9 shared papers)Mahmut Akpek (6 shared papers)Orhan Doğdu (5 shared papers)Mehmet Tuğrul İnanç (6 shared papers)
In The Last Decade
Şaban Keleşoğlu
37 papers receiving 355 citations
Peers
Comparison fields: 5 of 56
- Internal Medicine 51
- Cardiology and Cardiovascular Medicine 212
- Nephrology 44
- Oncology 112
- Immunology 48
Countries citing papers authored by Şaban Keleşoğlu
This map shows the geographic impact of Şaban Keleşoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Şaban Keleşoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Şaban Keleşoğlu more than expected).
Fields of papers citing papers by Şaban Keleşoğlu
This network shows the impact of papers produced by Şaban Keleşoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Şaban Keleşoğlu. The network helps show where Şaban Keleşoğlu may publish in the future.
Co-authors
The 25 scholars most cited alongside Şaban Keleşoğlu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 45 | |
| 2 | 2021 | 35 | |
| 3 | 2021 | 26 | |
| 4 | 2011 | 24 | |
| 5 | 2021 | 23 | |
| 6 | 2010 | 21 | |
| 7 | 2011 | 20 | |
| 8 | 2024 | 19 | |
| 9 | 2011 | 17 | |
| 10 | 2022 | 16 | |
| 11 | 2022 | 14 | |
| 12 | 2023 | 11 | |
| 13 | 2022 | 11 | |
| 14 | 2014 | 10 | |
| 15 | 2014 | 10 | |
| 16 | 2024 | 7 | |
| 17 | 2023 | 7 | |
| 18 | 2021 | 7 | |
| 19 | 2021 | 6 | |
| 20 | 2024 | 6 |
About Şaban Keleşoğlu
Şaban Keleşoğlu is a scholar working on Cardiology and Cardiovascular Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Nephrology and Surgery, having authored 43 papers that have together received 364 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (11 papers), Atrial Fibrillation Management and Outcomes (9 papers), Cardiovascular Disease and Adiposity (8 papers), Acute Myocardial Infarction Research (8 papers), Cardiac Imaging and Diagnostics (7 papers), Venous Thromboembolism Diagnosis and Management (6 papers), Acute Kidney Injury Research (5 papers) and Chronic Kidney Disease and Diabetes (3 papers). The work is most often cited by research in Internal Medicine (51 citations), Cardiology and Cardiovascular Medicine (212 citations), Nephrology (44 citations), Oncology (112 citations) and Immunology (48 citations). Şaban Keleşoğlu has collaborated with scholars based in Türkiye, Cambodia and Somalia. Frequent co-authors include Yücel Yılmaz, Deniz Elçik, Nihat Kalay, Abdurrahman Oğuzhan, Mehmet Güngör Kaya, Mahmut Akpek, Orhan Doğdu, Mehmet Tuğrul İnanç, İdris Ardıç and Mikail Yarlıoğlueş. Their work appears in journals such as Journal of Clinical Medicine, Biomarkers in Medicine, Journal of Investigative Medicine, The Journal of Rheumatology and Scandinavian Journal of Clinical and Laboratory Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.